CDT Equity (CDT) Other financing activities (2022 - 2024)
CDT Equity's (CDT) quarterly Other financing activities came in at $200000.0 in Q4 2024, up 20100.0% YoY from N/an in Q1 2024, and up 19900.0% on a QoQ basis from $1000.0 in Q3 2024.
CDT Equity (CDT) Other financing activities (2022 - 2024) Analysis & Trends
CDT Equity (CDT) has 3 years of Other financing activities data on file, last reported at $200000.0 in Q4 2024.
- Quarterly Other financing activities rose 20100.0% year-over-year to $200000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $400000.0 (down 94.69% YoY) and the FY2025 annual result came in at $6.6 million, up 5740.71% from the prior year.
- Other financing activities rose to $200000.0 in Q4 2024, from $1000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $132.2 million in Q1 2022 to a low of -$124.7 million in Q3 2022.
- A 3-year average of $2.2 million and a median of $200000.0 in 2024 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2023 — Other financing activities tumbled 94.3% — and 2024, when it soared 20100.0%.
- Tracing CDT's Other financing activities over 3 years: stood at -$124.7 million in 2022, then jumped by 100.0% to -$1000.0 in 2023, then soared by 20100.0% to $200000.0 in 2024.
- The last three Other financing activities figures came in at $200000.0 (Q4 2024), $1000.0 (Q3 2024), and $200000.0 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.54 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn |
| 4 | Moderna | 59.41 Bn | 54.27 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.07 Bn | 9.68 Bn | 668.28 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.44 Bn | - |
| 10 | CDT Equity | 1.60 Mn | 1.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 200,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Dec 31, 2023 | -1,000.00 |
| Dec 31, 2023 | -1,000.00 |
| Mar 31, 2023 | 7.54 Mn |
| Mar 31, 2023 | 7.54 Mn |
| Sep 30, 2022 | -124.71 Mn |
| Sep 30, 2022 | -124.71 Mn |
| Mar 31, 2022 | 132.25 Mn |
| Mar 31, 2022 | 132.25 Mn |